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Alcohol is a tumor promoter.1 Alcohol is involved in tumor promotion by not only
alcohol itself but also the derivatives of alcohol, such as acetaldehyde and free radicals
that are generated in the metabolic process. For example, acetaldehyde, proteins, and
DNA may form adduct, which leads to genetic mutations that induce tumorigenesis.
Alcohol abuse is defined as intake of alcohol that exceeds 21 units weekly or 3 units
per day. Alcohol abuse is a major risk factor for tumors, especially the upper gastrointestinal tract (oral cavity, pharynx, larynx, and esophagus) tumors, hepatocellular
carcinoma (HCC), colorectal cancer, and breast cancer.2–6 Furthermore, in many types
of tumors, including gastrointestinal tract, gynecological, brain, and renal tumors, the
activity of alcohol dehydrogenase is significantly increased.7
Alcohol exposure also enhances the progression and metastasis of a variety
of tumors, such as skin, liver, lung, breast, and colon cancers.8–13 Chronic alcohol
consumption is often associated with poor clinical prognosis.9 However, the underlying
cellular and molecular mechanisms are complex.
Alcohol consumption is one of the risk factors that correlate with high cancer
mortality rates,14 and this is mainly because chronic alcohol consumption often
leads to advanced TNM stages, greater vessel invasion, and poorer prognosis.9 The
underlying mechanism may be that alcohol consumption activates the expression of
some cytokines, such as VEGF, MCP-1, and NF-κ B, which are associated with tumor
progression and metastasis.8–10
This review discusses the current research progress in the cellular and molecular
mechanisms underlying alcohol-induced tumor promotion. We specifically focus on
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Abstract: Excessive chronic alcohol consumption has become a worldwide health problem. The
oncogenic effect of chronic alcohol consumption is one of the leading concerns. The mechanisms
of alcohol-induced tumorigenesis and tumor progression are largely unknown, although many
factors have been implicated in the process. This review discusses the recent progress in this
research area with concentration on alcohol-induced dysregulation of cytokines and chemokines.
Based on the available evidence, we propose that alcohol promotes tumor progression by the
dysregulation of the cytokine/chemokine system. In addition, we discuss specific transcription
factors and signaling pathways that are involved in the action of these cytokines/chemokines
and the oncogenic effect of alcohol. This review provides novel insight into the mechanisms
of alcohol-induced tumor promotion.
Keywords: alcohol, tumor promotion, cytokines, chemokines, transcription factors, signal
transduction, therapy
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the role of cytokines and chemokines in alcohol-promoted
tumor progression and aggressiveness.
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Alcohol-induced dysregulation of
cytokines and chemokines
Cytokines are small molecule proteins with a broad range
of biological activities. They are normally synthesized and
secreted by the immune cells, such as monocytes, macrophages, T cells, B cells, and natural killer cells, as well
as some nonimmune cells, such as endothelial cells and
fibroblasts. Cytokines regulate cell growth and differentiation
by binding to the specific receptors and mediate the immune
response.15,16 Chemokines are chemotactic cytokines that
mediate the migration and positioning of the target cells.17
In addition to mediating immune response, chemokines are
also involved in regulating the embryonic development,
angiogenesis, and apoptosis. More importantly, chemokines
are now known to play a vital role in tumorigenesis, tumor
progression, and metastasis.18,19 The most well-investigated
cytokines and chemokines include VEGF, MCP-1, TLR,
and TNF-α. Alcohol exposure affects the cytokine and
chemokine systems.20–22 Particularly, the effects of alcohol
on VEGF and MCP-1 receive great attention due to their
roles in tumorigenesis and progression.

VEGF
VEGF is a highly conservative glycoprotein23,24 and plays
an important role in angiogenesis, invasion of tumors,25,26
cell proliferation, and vascular permeability.27–29 VEGF is
significantly upregulated in tumor tissues and positively
correlated with malignancy.30,31 It is proposed that alcohol
promotes tumor growth, angiogenesis, and metastasis in
skin cancer, liver cancer, and breast cancer by increasing
the VEGF levels.8,32 In addition, oxidative stress and NF-κ B
mediate the alcohol-induced VEGF upregulation.9 However,
the exact signaling mechanisms are still largely unknown.

MCP-1
MCP-1, also called CCL2, activates the mononuclear cells
and macrophages by increasing the intracytoplasmic Ca2+ concentration and releasing the superoxide anion and lysozyme.33
Moreover, many studies also demonstrated that MCP-1
plays essential roles in tumor microenvironment by regulating tumor angiogenesis, tumor growth, and metastasis.34–36
Alcohol exposure upregulates MCP-1 and recruits M2
macrophages in tumor microenvironment, which, in turn, promotes the growth and metastasis of lung cancer (Figure 1).10
More importantly, it is reported that alcohol promotes
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Figure 1 Role of VEGF and MCP-1 in alcohol-induced tumor growth and
metastasis.
Notes: Alcohol exposure upregulates VEGF level, thus promoting angiogenesis of
endothelial cells. Alcohol exposure activates MCP-1 and recruits M2 macrophages,
which, in turn, promotes the growth and metastasis of cancer cells.

the growth and angiogenesis of breast cancer through
activation of MCP-1 and its receptor CCR2 (Figure 1).11
Consistent with this idea, antagonists of CCR2 can inhibit
tumor angiogenesis induced by alcohol.11 Alcohol can also
promote the migration and invasion of colorectal cancer cells
(CSCs) by regulating the GSK3β/β-catenin/MCP-1 signaling
pathway.12 However, the exact mechanisms of how MCP-1
mediated the effects, ie, alcohol stress-induced tumorigenesis
and tumor growth, are still unclear.

TLR
TLR is a type I transmembrane receptor and pathogenic
pattern recognition receptor, which participates in natural
immunity. TLR plays an important role in cellular immune
responses.37 Furthermore, some cytokines also regulate stem
cells. For example, TLR induces NANOG gene expression,
which is involved in the regulation of tumor-initiating stemlike cells (TICs).38
Recent studies found that TLR may play an important role
in alcohol-induced liver cancer by regulating the TICs,38 at
least partially through Nanog, one of the embryonic stem cell
markers, which, in turn, regulates the proliferation and differentiation of liver stem/progenitor cells.39 Once activated, the
proportion of CD133/Nanog-positive cells increased in liver
cancer.40 Conversely, knocking off TLR genes can prevent
tumor growth to a certain extent.41 Interestingly, studies
found that ethanol-treated malignant cells fused to dendritic
cells (DCs) exposed to TLR stimulation, thus promoting
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abnormal cellular immune response, which is thought to be
an important mechanism of tumor promotion.42
Overall, these data suggested that chronic alcohol stress
may play an important role in tumor promotion at least
partially through the TLR/Nanog pathway.
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TNF-α
TNF-α is a type II membrane protein, which is mainly
secreted by the activated mononuclear macrophages and
could act either as a tumor suppressor or as an oncogene.
TNF-α plays an antitumor role by inducing apoptosis, inhibiting tumor angiogenesis, and enhancing host immunity.43,44
TNF-α also acts as an oncogene by upregulating inflammatory
cytokines, inhibiting apoptosis, and activating multiple signaling pathways, causing tumor-associated gene mutation.45,46
The increased TNF-α in tumor microenvironment can
promote tumor cell migration and invasion,47 which is associated with metastasis, recurrence, and poor prognosis of cancer
patients.48 More importantly, chronic ethanol exposure can
upregulate TNF-α, which, in turn, facilities infiltration of
monocytes/macrophages in liver and, therefore, promotes
liver lesions. For instance, TNF increased significantly in the
liver tissue of alcohol-fed mice.49 However, the underlying
mechanisms of TNF-α variation in alcohol-induced tumor
promotion need to be further explored.

Alcohol-induced dysregulation of
transcription factors mediated by
cytokines and chemokines
Cytokines and chemokines directly or indirectly regulate
transcription factors, which play key roles in integrating
the multiple extracellular signaling pathways and regulating gene expression. The transcription factors known to
be regulated by cytokines and chemokines include Egr-1,
AP-1, and STAT.
Alcohol exposure affects the activity of transcription
factors. Some of these transcription factors are known to be
involved in the action of cytokines and chemokines as well
as tumorigenesis/progression.50–53 In the present study, we
focus on the three transcription factors that are affected by
alcohol exposure, namely, Egr-1, STAT, and AP-1.

Egr-1
Egr-1 is a nuclear transcription factor that is regulated by
the mitogen-activated protein kinase (MAPK) signaling
pathway.54 Egr-1 binds to the promoter region of TNF-α
and increases the sensitivity of liver macrophages.55 Egr-1
is upregulated in the process of alcoholic cirrhosis.50
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Lipopolysaccharide (LPS)-induced activation of Egr-1 in
the liver Kupffer cells contributes to the pathogenesis of
alcoholic liver disease.51 In addition, chronic alcohol exposure also induces Egr-1 to bind to the promoter region of the
TNF-α and increases the sensitivity of liver macrophages.55
Alcohol-induced liver cirrhosis may in the long run increase
the risk of liver carcinogenesis.
Egr-1 also plays an important role in the process of
tumorigenesis.56 Egr-1 has been found highly expressed in
gastric cancer and bladder cancer,57,58 and it may upregulate
invasion and metastasis-related genes, such as matrix metalloproteinases (MMP3).59 However, whether alcohol promotes
tumor metastasis by activating Egr-1 is largely unknown.

STAT
The activity of STAT is regulated by JAK-mediated signal transduction, which can be activated by cytokines and
chemokines.60 MAPK/STAT3 signaling pathway increases
the DNA binding ability of AP-1 through the activation of
Src kinases, thereby inducing the production of IL-10.61,62
During alcoholic liver injury, STAT3 modulates the
liver immune response in a cell-type-dependent manner. For
example, in liver cells, STAT3 exerts a pro-inflammatory role,
whereas in mononuclear cells and Kupffer cells, STAT3
plays an anti-inflammatory role.52 In addition, the decreased
liver regeneration capacity of patients with alcoholic cirrhosis
is related to the decreased activity of STAT3, revealing a
positive correlation between STAT3 and liver regeneration
ability.53 Nevertheless, it is still unclear how ethanol exposure
regulates STAT3 in liver cancer.

AP-1
AP-1 is a transcription factor that belongs to the leucine
zipper protein family.63 AP-1 responds to cytokines by regulating the expression of a number of genes related to carcinogenesis and tumor progression. AP-1 and other transcription
factors, including STAT3, SP-1, and SP-3, are all involved
in LPS-induced production of IL-10 in monocytes and
T cells.64–67 Meanwhile, it has been demonstrated that alcohol exposure activates the Src/MAPK/STAT3 signaling
pathway and increases the DNA binding ability of AP-1,
thereby inducing the production of IL-10.61 In the context
of liver injury, alcohol exposure enhances the sensitivity of
liver macrophages via upregulating AP-1 and increasing
the expression of CD14.68 Alcohol exposure can also activate AP-1 in a protein kinase C (PKC)-dependent manner
and enhance proliferation ability of liver cells by increasing the expression of c-Jun and c-Fos in the liver cells.69
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Alcohol-induced liver injury may also in the long run
increase the risk of liver carcinogenesis.
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Alcohol-induced dysregulation of
signaling pathways in the action of
cytokines and chemokines
There are a number of signaling pathways that are regulated
by cytokines and chemokines and play an important role in
tumorigenesis and progression. On the other hand, these
signaling pathways can also modulate the expression of
cytokines and chemokines. The most important signaling
pathways involved in the action of cytokines and chemokines are NF-κ B-TNF-α signaling pathway, MAPK signaling
pathway, and Wnt/β-catenin signaling pathway.
Alcohol can cause the dysregulation of some signaling
pathways that are involved in the action of cytokines,
chemokines, tumorigenesis, and progression. In the present
review, we discuss the three most important signaling
pathways affected by alcohol exposure.

NF-κ B-TNF-α signaling pathway
TNF-α is involved in multiple signaling pathways and can
activate NF-κ B which, in turn, also participates in regulating
TNF-α.70 LPS-induced oxidative stress activates NF-κ B,
increasing TNF-α production in Kupffer cells. LPS activates
Kupffer cells and induces the production of superoxides that
activate NF-κ B. Once activated, NF-κ B is translocated to
the nucleus and regulates the expression of several critical
inflammatory cytokines, particularly TNF-α.71 Blocking the
activation of NF-κ B markedly decreases cytokine production and ameliorates inflammation and necrosis.72 It has
been reported that alcohol-induced liver damage is associated with the activation of the NF-κ B signaling pathway as
well as the high expression of pro-inflammatory cytokines
and upregulation of TLR3 and TLR7.73 It is believed that
alcohol exposure regulates the inflammatory response of
hepatic macrophages at least partially through the NF-κ B
signaling pathway. Alcohol can activate the NF-κB signaling
pathway by affecting its nuclear localization, formation of
NF-κ B p65/p50 dimmers, and DNA binding activity.71,73,74
In the mouse model of alcohol-induced liver injury, alcohol
consumption causes a significant increase in DNA binding
activity of NF-κ B in the liver.73
Our recent study demonstrated that alcohol exposure
activates the NF-κ B signaling pathway and upregulates
its target cytokines and chemokines, VEGF and MCP-1,
which promote angiogenesis, growth, and metastasis of liver
cancer cells.9
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MAPK signaling pathway
MAPK signaling pathway is involved in mediating the
tumorigenesis and metastasis.75 Cytokines and chemokines
can activate three members of the MAPK family, namely,
ERK1/2, p38 MAPK, and JNK/SAPK.76,77 Among them, the
p38 MAPK pathway is required for the induction of TNF-αRNA-binding activity and mediates stabilization of TNF-α
mRNA in myeloid cells stimulated with bacterial LPS.78
Alcohol affects the MAPK family and activates the three
members of this family, namely ERK, p38 MAPK, and JNKs.
A recent study showed that alcohol promotes malignant
progression of breast cancer by activating the p38γ MAPK/
RhoC signaling pathway.79 Alcohol activates p38 MAPK
in mononuclear cells, which generates anti-inflammatory
cytokines such as IL-10.80 Similarly, it is reported that alcohol
stimulates the liver macrophages to produce TNF-α through
the activation of ERK1/2.81 Alcohol exposure also activates
Src/MAPK/STAT3 and increases the binding ability of
AP-1.61 Meanwhile, JNK was activated by alcohol in breast
cancer cells and required for alcohol-induced cell invasion.82
Since MAPKs play an important role in tumorigenesis and
progression, the effect of alcohol on MAPKs has a significant
impact on tumor promotion.

Wnt/β-catenin signaling pathway
Wnt/β-catenin signaling pathway regulates tumor growth
and metastasis83 as well as self-renewal and differentiation
of cancer stem cells.84 Some cytokines are implicated in
the regulation of Wnt/β-catenin signaling. On the one hand
cytokine such as TNF-α activates Wnt/β-catenin signaling, on the other hand Wnt/β-catenin signaling also affects
specific cytokines.34,85,86 For example, IL-1β and TNF-α
induced rat nucleus pulposus cells apoptosis by activating
the caveolin-1/Wnt/β-catenin signaling pathway.85 TNF-αinduced NF-κ B activation inhibits osteogenesis of mesenchymal stem cells by targeting Wnt/β-catenin signaling.86
Furthermore, MCP-1 is a target of the β-catenin/TCF/LEF
pathway in breast tumor cells and plays a key role in breast
tumor progression.34
Recent studies demonstrated that alcohol activates the
Wnt/β-catenin signaling pathway and promotes malignant
proliferation of cancer cells and tumor formation in the
liver.87,88 Our previous study found that the Wnt/β-catenin
pathway mediates alcohol-stimulated MCP-1 gene transcription and enhances CSC metastasis.12 Whether the Wnt/βcatenin signaling pathway is activated by alcohol stress in
other tumors, such as breast cancer, colon cancer, and the
underlying molecular mechanisms are undiscovered.
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Cytokines and chemokines as
potential therapeutic targets
Cytokines and chemokines are potential therapeutic targets
for the treatment of alcohol-induced tumor promotion as
well as other alcohol-related diseases. They may be used
as biomarkers for alcohol-induced organ damage. For
example, MCP-1 levels in cerebrospinal fluid, together with
gamma glutamyltransferase (GGT) and aspartate aminotransferase/glutamic oxaloacetic transaminase (AST/GOT)
in peripheral blood, are indicators of clinical alcoholic
hepatitis in alcoholics.89 Recent studies showed that blocking
NF-κ B-regulated MCP-1 and VEGF expression inhibits
alcohol-induced tumor formation ability of liver cancer
cells.9 Similarly, blocking Wnt/β-catenin signaling inhibits
alcohol-stimulated MCP-1 expression and alleviates alcoholinduced invasion of colon cancer cells.12 These studies suggest
that targeting cytokines and chemokines may be a potential
therapeutic strategy for cancer treatment, particularly in the
context of alcohol-induced tumor promotion.

Conclusion

• Excessive alcohol consumption is a risk factor for cancer.
Alcohol promotes tumorigenesis, progression, and
metastasis.
• Alcohol causes dysregulation of cytokines and chemokines, which may mediate alcohol-induced tumor promotion. Alcohol may also affect transcription factors and
signaling pathways that regulate the expression/function
of cytokines and chemokines.
• Systematic screening of cytokines and chemokines that
are affected by alcohol during tumorigenesis and cancer
progression is necessary for providing more insight into
the role of cytokines and chemokines in alcohol-induced
tumor promotion. Targeting cytokines and chemokines
could be a potential therapeutic strategy for cancer
treatment, particularly in the context of alcohol-induced
tumor promotion/progression.
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